Meningitis A close to elimination in African meningitis belt thanks to MenAfriVac vaccine

Global vaccine experts and officials from all 26 African "meningitis belt" countries have convened in Addis Ababa, Ethiopia to celebrate one of Africa's biggest public health achievements-the introduction of a vaccine, MenAfriVac(R), designed, developed, and produced for use in Africa, that in five years of use has nearly eliminated serogroup A meningococcal disease from meningitis ["]